|
|
|
501-1,000 employees
View all
|
|
biotechnology
|
|
Semmelweisstr. 7,Planegg,Bayern,DE
|
|
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development and commercialization of exceptional, innovative therapies for patients suffering from serious diseases, with a focus on cancer. Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed to the development of more than 100 product candidates, of which 27 are currently in clinical development. MorphoSys is listed on the Frankfurt Stock Exchange and NASDAQ under the symbol MOR. Headquartered in Planegg near Munich, Germany, the MorphoSys group includes the fully owned U.S. subsidiary MorphoSys US Inc. based in Boston, MA.
|
MorphoSys Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
81.25%
|
The widely used MorphoSys email format is {first}.{last} (e.g. [email protected]) with 81.25% adoption across the company.
To contact MorphoSys customer service number in your country click here to find.
Jean-paul Kress is the CEO of MorphoSys.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.